CA1339466C - Vaccine - Google Patents

Vaccine

Info

Publication number: CA1339466C
Authority: CA; Canada
Prior art keywords: immunogen; ticks; wgl; dna; antigen
Prior art date: 1986-11-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA 552826

Other languages

English (en)

French (fr)

Inventor

Law Anthony Yorke Johnston

Alagacone Sriskantha

Peter Willadsen

David Harold Kemp

Keith Norman Rand

George Alfred Riding

Gary Stewart Cobon

Joanna Terry Moore

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Commonwealth Scientific and Industrial Research Organization CSIRO

Inhibin Pty Ltd

Original Assignee

Commonwealth Scientific and Industrial Research Organization CSIRO

Biotechnology Australia Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-11-27

Filing date

1987-11-26

Publication date

1997-09-16

1987-11-26 Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Biotechnology Australia Pty Ltd filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO

1997-09-16 Application granted granted Critical

1997-09-16 Publication of CA1339466C publication Critical patent/CA1339466C/en

2014-09-16 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 32
102000036639 antigens Human genes 0.000 claims abstract description 175
108091007433 antigens Proteins 0.000 claims abstract description 175
239000000427 antigen Substances 0.000 claims abstract description 174
241000238876 Acari Species 0.000 claims abstract description 123
241000283690 Bos taurus Species 0.000 claims abstract description 39
108020004511 Recombinant DNA Proteins 0.000 claims abstract description 16
201000001064 tick infestation Diseases 0.000 claims abstract description 9
238000000034 method Methods 0.000 claims description 89
108020004414 DNA Proteins 0.000 claims description 79
108090000765 processed proteins & peptides Proteins 0.000 claims description 76
108091028043 Nucleic acid sequence Proteins 0.000 claims description 55
239000000523 sample Substances 0.000 claims description 51
239000000872 buffer Substances 0.000 claims description 50
230000002163 immunogen Effects 0.000 claims description 50
239000000463 material Substances 0.000 claims description 50
210000004027 cell Anatomy 0.000 claims description 46
102000004196 processed proteins & peptides Human genes 0.000 claims description 38
239000002299 complementary DNA Substances 0.000 claims description 37
230000008569 process Effects 0.000 claims description 37
229920002684 Sepharose Polymers 0.000 claims description 33
241000238680 Rhipicephalus microplus Species 0.000 claims description 30
238000009396 hybridization Methods 0.000 claims description 28
229920001184 polypeptide Polymers 0.000 claims description 28
230000036039 immunity Effects 0.000 claims description 25
230000028993 immune response Effects 0.000 claims description 23
108010046516 Wheat Germ Agglutinins Proteins 0.000 claims description 22
238000002360 preparation method Methods 0.000 claims description 19
BHATUINFZWUDIX-UHFFFAOYSA-N Zwittergent 3-14 Chemical compound CCCCCCCCCCCCCC[N+](C)(C)CCCS([O-])(=O)=O BHATUINFZWUDIX-UHFFFAOYSA-N 0.000 claims description 18
239000003599 detergent Substances 0.000 claims description 18
238000004128 high performance liquid chromatography Methods 0.000 claims description 17
239000013598 vector Substances 0.000 claims description 17
108090001090 Lectins Proteins 0.000 claims description 16
102000004856 Lectins Human genes 0.000 claims description 16
238000004458 analytical method Methods 0.000 claims description 16
238000004587 chromatography analysis Methods 0.000 claims description 16
239000002523 lectin Substances 0.000 claims description 16
108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 15
206010061217 Infestation Diseases 0.000 claims description 15
239000000126 substance Substances 0.000 claims description 15
239000013612 plasmid Substances 0.000 claims description 14
102000053602 DNA Human genes 0.000 claims description 13
230000001580 bacterial effect Effects 0.000 claims description 12
239000012528 membrane Substances 0.000 claims description 12
241001480755 Otobius Species 0.000 claims description 11
241001494479 Pecora Species 0.000 claims description 11
230000015572 biosynthetic process Effects 0.000 claims description 11
238000001155 isoelectric focusing Methods 0.000 claims description 11
241001480796 Haemaphysalis Species 0.000 claims description 10
230000003247 decreasing effect Effects 0.000 claims description 10
108090000288 Glycoproteins Proteins 0.000 claims description 8
102000003886 Glycoproteins Human genes 0.000 claims description 8
OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims description 8
241000864246 Rhipicephalus decoloratus Species 0.000 claims description 8
102000040430 polynucleotide Human genes 0.000 claims description 8
108091033319 polynucleotide Proteins 0.000 claims description 8
239000002157 polynucleotide Substances 0.000 claims description 8
244000115658 Dahlia pinnata Species 0.000 claims description 7
241001480824 Dermacentor Species 0.000 claims description 7
241001480819 Dermacentor andersoni Species 0.000 claims description 7
241001480803 Hyalomma Species 0.000 claims description 7
241000238681 Ixodes Species 0.000 claims description 7
241000922049 Ixodes holocyclus Species 0.000 claims description 7
OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 7
MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims description 7
241001480837 Rhipicephalus annulatus Species 0.000 claims description 7
239000002671 adjuvant Substances 0.000 claims description 7
210000000170 cell membrane Anatomy 0.000 claims description 7
238000005119 centrifugation Methods 0.000 claims description 7
229950006780 n-acetylglucosamine Drugs 0.000 claims description 7
238000011282 treatment Methods 0.000 claims description 7
230000003302 anti-idiotype Effects 0.000 claims description 6
241000238679 Amblyomma Species 0.000 claims description 5
240000004808 Saccharomyces cerevisiae Species 0.000 claims description 5
238000003776 cleavage reaction Methods 0.000 claims description 5
238000010828 elution Methods 0.000 claims description 5
230000001850 reproductive effect Effects 0.000 claims description 5
230000007017 scission Effects 0.000 claims description 5
238000001542 size-exclusion chromatography Methods 0.000 claims description 5
241000223838 Babesia bovis Species 0.000 claims description 4
108020004705 Codon Proteins 0.000 claims description 4
241000588724 Escherichia coli Species 0.000 claims description 4
241000238631 Hexapoda Species 0.000 claims description 4
241001299692 Theileria lestoquardi Species 0.000 claims description 4
244000042288 Trichotosia annulata Species 0.000 claims description 4
238000011210 chromatographic step Methods 0.000 claims description 4
201000010099 disease Diseases 0.000 claims description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
238000000926 separation method Methods 0.000 claims description 4
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims description 4
HBOMLICNUCNMMY-KJFJCRTCSA-N 1-[(4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-KJFJCRTCSA-N 0.000 claims description 3
241000605314 Ehrlichia Species 0.000 claims description 3
239000003795 chemical substances by application Substances 0.000 claims description 3
230000002255 enzymatic effect Effects 0.000 claims description 3
238000000338 in vitro Methods 0.000 claims description 3
210000003000 inclusion body Anatomy 0.000 claims description 3
230000001939 inductive effect Effects 0.000 claims description 3
238000003998 size exclusion chromatography high performance liquid chromatography Methods 0.000 claims description 3
239000002195 soluble material Substances 0.000 claims description 3
238000013519 translation Methods 0.000 claims description 3
241000701447 unidentified baculovirus Species 0.000 claims description 3
230000003612 virological effect Effects 0.000 claims description 3
241000283707 Capra Species 0.000 claims description 2
241000282994 Cervidae Species 0.000 claims description 2
241000282326 Felis catus Species 0.000 claims description 2
241001480756 Otobius megnini Species 0.000 claims description 2
238000012258 culturing Methods 0.000 claims description 2
IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 claims description 2
239000003085 diluting agent Substances 0.000 claims description 2
230000000091 immunopotentiator Effects 0.000 claims description 2
239000002773 nucleotide Substances 0.000 claims description 2
125000003729 nucleotide group Chemical group 0.000 claims description 2
125000003275 alpha amino acid group Chemical group 0.000 claims 4
241001480834 Amblyomma variegatum Species 0.000 claims 2
241000179420 Haemaphysalis longicornis Species 0.000 claims 2
241001481703 Rhipicephalus <genus> Species 0.000 claims 2
241000606665 Anaplasma marginale Species 0.000 claims 1
241000283073 Equus caballus Species 0.000 claims 1
241000009328 Perro Species 0.000 claims 1
241000282898 Sus scrofa Species 0.000 claims 1
244000085129 Turpinia parva Species 0.000 claims 1
HOVAGTYPODGVJG-VEIUFWFVSA-N methyl alpha-D-mannoside Chemical compound CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O HOVAGTYPODGVJG-VEIUFWFVSA-N 0.000 claims 1
238000000088 particle-induced gamma-ray emission spectroscopy Methods 0.000 claims 1
238000000163 radioactive labelling Methods 0.000 claims 1
230000001131 transforming effect Effects 0.000 claims 1
108090000623 proteins and genes Proteins 0.000 abstract description 84
238000000746 purification Methods 0.000 abstract description 20
238000010367 cloning Methods 0.000 abstract description 4
230000004071 biological effect Effects 0.000 abstract 1
238000003259 recombinant expression Methods 0.000 abstract 1
150000001413 amino acids Chemical group 0.000 description 96
235000001014 amino acid Nutrition 0.000 description 61
229940024606 amino acid Drugs 0.000 description 61
239000012634 fragment Substances 0.000 description 51
241001465754 Metazoa Species 0.000 description 47
235000018102 proteins Nutrition 0.000 description 46
102000004169 proteins and genes Human genes 0.000 description 46
241000894007 species Species 0.000 description 46
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 43
238000006243 chemical reaction Methods 0.000 description 32
239000000499 gel Substances 0.000 description 30
239000000243 solution Substances 0.000 description 30
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 28
239000000203 mixture Substances 0.000 description 27
108091034117 Oligonucleotide Proteins 0.000 description 26
238000002474 experimental method Methods 0.000 description 25
230000001681 protective effect Effects 0.000 description 23
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 22
235000019333 sodium laurylsulphate Nutrition 0.000 description 22
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 20
239000000047 product Substances 0.000 description 18
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 16
239000007983 Tris buffer Substances 0.000 description 15
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 15
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 15
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 14
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 14
229920002678 cellulose Polymers 0.000 description 13
239000001913 cellulose Substances 0.000 description 13
239000000306 component Substances 0.000 description 13
230000029087 digestion Effects 0.000 description 13
238000000605 extraction Methods 0.000 description 13
238000002955 isolation Methods 0.000 description 13
229920002873 Polyethylenimine Polymers 0.000 description 12
239000006228 supernatant Substances 0.000 description 12
238000002255 vaccination Methods 0.000 description 12
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 11
108010033276 Peptide Fragments Proteins 0.000 description 11
102000007079 Peptide Fragments Human genes 0.000 description 11
229920002401 polyacrylamide Polymers 0.000 description 11
108091008146 restriction endonucleases Proteins 0.000 description 11
239000011780 sodium chloride Substances 0.000 description 11
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
101710194807 Protective antigen Proteins 0.000 description 10
235000013601 eggs Nutrition 0.000 description 10
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 9
101001018085 Lysobacter enzymogenes Lysyl endopeptidase Proteins 0.000 description 9
108010038807 Oligopeptides Proteins 0.000 description 9
102000015636 Oligopeptides Human genes 0.000 description 9
238000013459 approach Methods 0.000 description 9
238000004519 manufacturing process Methods 0.000 description 9
238000003786 synthesis reaction Methods 0.000 description 9
241000894006 Bacteria Species 0.000 description 8
238000012300 Sequence Analysis Methods 0.000 description 8
DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
244000005700 microbiome Species 0.000 description 8
239000008188 pellet Substances 0.000 description 8
239000012071 phase Substances 0.000 description 8
USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 7
239000005695 Ammonium acetate Substances 0.000 description 7
229940043376 ammonium acetate Drugs 0.000 description 7
235000019257 ammonium acetate Nutrition 0.000 description 7
238000010276 construction Methods 0.000 description 7
238000001502 gel electrophoresis Methods 0.000 description 7
230000002209 hydrophobic effect Effects 0.000 description 7
108010034897 lentil lectin Proteins 0.000 description 7
150000007523 nucleic acids Chemical group 0.000 description 7
244000045947 parasite Species 0.000 description 7
239000002244 precipitate Substances 0.000 description 7
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 6
102100034343 Integrase Human genes 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
239000000020 Nitrocellulose Substances 0.000 description 6
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
239000011543 agarose gel Substances 0.000 description 6
238000013461 design Methods 0.000 description 6
238000011161 development Methods 0.000 description 6
230000018109 developmental process Effects 0.000 description 6
230000000694 effects Effects 0.000 description 6
238000005194 fractionation Methods 0.000 description 6
230000006870 function Effects 0.000 description 6
-1 methyl- Chemical group 0.000 description 6
229920001220 nitrocellulos Polymers 0.000 description 6
108020004707 nucleic acids Proteins 0.000 description 6
102000039446 nucleic acids Human genes 0.000 description 6
YPJUNDFVDDCYIH-UHFFFAOYSA-N perfluorobutyric acid Chemical compound OC(=O)C(F)(F)C(F)(F)C(F)(F)F YPJUNDFVDDCYIH-UHFFFAOYSA-N 0.000 description 6
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 6
ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 6
PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 6
101710203526 Integrase Proteins 0.000 description 5
239000004472 Lysine Substances 0.000 description 5
108010030544 Peptidyl-Lys metalloendopeptidase Proteins 0.000 description 5
108091000080 Phosphotransferase Proteins 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
230000000295 complement effect Effects 0.000 description 5
238000001962 electrophoresis Methods 0.000 description 5
230000003053 immunization Effects 0.000 description 5
238000002649 immunization Methods 0.000 description 5
238000011534 incubation Methods 0.000 description 5
229910001629 magnesium chloride Inorganic materials 0.000 description 5
230000004719 natural immunity Effects 0.000 description 5
102000020233 phosphotransferase Human genes 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
238000011160 research Methods 0.000 description 5
239000000725 suspension Substances 0.000 description 5
238000004809 thin layer chromatography Methods 0.000 description 5
229920000936 Agarose Polymers 0.000 description 4
241000238678 Boophilus Species 0.000 description 4
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
241000206602 Eukaryota Species 0.000 description 4
DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
108091005804 Peptidases Proteins 0.000 description 4
102000035195 Peptidases Human genes 0.000 description 4
239000002253 acid Substances 0.000 description 4
210000004369 blood Anatomy 0.000 description 4
239000008280 blood Substances 0.000 description 4
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 4
235000011089 carbon dioxide Nutrition 0.000 description 4
RGWHQCVHVJXOKC-SHYZEUOFSA-N dCTP Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO[P@](O)(=O)O[P@](O)(=O)OP(O)(O)=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-N 0.000 description 4
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 4
238000012869 ethanol precipitation Methods 0.000 description 4
238000010348 incorporation Methods 0.000 description 4
239000011347 resin Substances 0.000 description 4
229920005989 resin Polymers 0.000 description 4
230000000717 retained effect Effects 0.000 description 4
238000012163 sequencing technique Methods 0.000 description 4
HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 4
238000005406 washing Methods 0.000 description 4
IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 3
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 3
241000283699 Bos indicus Species 0.000 description 3
108091026890 Coding region Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 3
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 3
ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 3
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 3
OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
108010090054 Membrane Glycoproteins Proteins 0.000 description 3
102000012750 Membrane Glycoproteins Human genes 0.000 description 3
239000004677 Nylon Substances 0.000 description 3
108020005187 Oligonucleotide Probes Proteins 0.000 description 3
VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
241000223779 Theileria parva Species 0.000 description 3
ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
229920004890 Triton X-100 Polymers 0.000 description 3
239000013504 Triton X-100 Substances 0.000 description 3
KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
238000002835 absorbance Methods 0.000 description 3
230000009471 action Effects 0.000 description 3
238000010171 animal model Methods 0.000 description 3
239000008346 aqueous phase Substances 0.000 description 3
239000012503 blood component Substances 0.000 description 3
238000010804 cDNA synthesis Methods 0.000 description 3
239000004202 carbamide Substances 0.000 description 3
238000012512 characterization method Methods 0.000 description 3
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
239000000284 extract Substances 0.000 description 3
238000000855 fermentation Methods 0.000 description 3
230000004151 fermentation Effects 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
239000007789 gas Substances 0.000 description 3
230000002068 genetic effect Effects 0.000 description 3
239000012535 impurity Substances 0.000 description 3
BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
108020004999 messenger RNA Proteins 0.000 description 3
229950006238 nadide Drugs 0.000 description 3
229920001778 nylon Polymers 0.000 description 3
239000002751 oligonucleotide probe Substances 0.000 description 3
235000019833 protease Nutrition 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000002441 reversible effect Effects 0.000 description 3
210000002966 serum Anatomy 0.000 description 3
239000001632 sodium acetate Substances 0.000 description 3
235000017281 sodium acetate Nutrition 0.000 description 3
229940063673 spermidine Drugs 0.000 description 3
239000007858 starting material Substances 0.000 description 3
239000001226 triphosphate Substances 0.000 description 3
235000011178 triphosphate Nutrition 0.000 description 3
230000035899 viability Effects 0.000 description 3
239000003643 water by type Substances 0.000 description 3
241000606646 Anaplasma Species 0.000 description 2
241000238426 Anostraca Species 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000223836 Babesia Species 0.000 description 2
108091003079 Bovine Serum Albumin Proteins 0.000 description 2
108020004635 Complementary DNA Proteins 0.000 description 2
108010062580 Concanavalin A Proteins 0.000 description 2
WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
102000012410 DNA Ligases Human genes 0.000 description 2
108010061982 DNA Ligases Proteins 0.000 description 2
108050009160 DNA polymerase 1 Proteins 0.000 description 2
238000002965 ELISA Methods 0.000 description 2
241000196324 Embryophyta Species 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
108010048188 MS2 polymerase Proteins 0.000 description 2
241000403354 Microplus Species 0.000 description 2
230000004988 N-glycosylation Effects 0.000 description 2
BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
239000012506 Sephacryl® Substances 0.000 description 2
229920005654 Sephadex Polymers 0.000 description 2
239000012507 Sephadex™ Substances 0.000 description 2
238000002105 Southern blotting Methods 0.000 description 2
241001066071 Theileria parva parva Species 0.000 description 2
239000007984 Tris EDTA buffer Substances 0.000 description 2
239000008351 acetate buffer Substances 0.000 description 2
238000001042 affinity chromatography Methods 0.000 description 2
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
229910052921 ammonium sulfate Inorganic materials 0.000 description 2
235000011130 ammonium sulphate Nutrition 0.000 description 2
SOIFLUNRINLCBN-UHFFFAOYSA-N ammonium thiocyanate Chemical compound [NH4+].[S-]C#N SOIFLUNRINLCBN-UHFFFAOYSA-N 0.000 description 2
238000003556 assay Methods 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
201000008680 babesiosis Diseases 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
229940098773 bovine serum albumin Drugs 0.000 description 2
210000004899 c-terminal region Anatomy 0.000 description 2
150000001720 carbohydrates Chemical group 0.000 description 2
239000000356 contaminant Substances 0.000 description 2
230000000875 corresponding effect Effects 0.000 description 2
ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 2
230000034994 death Effects 0.000 description 2
230000002939 deleterious effect Effects 0.000 description 2
238000001212 derivatisation Methods 0.000 description 2
238000001514 detection method Methods 0.000 description 2
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
230000003241 endoproteolytic effect Effects 0.000 description 2
210000003527 eukaryotic cell Anatomy 0.000 description 2
239000013604 expression vector Substances 0.000 description 2
238000010353 genetic engineering Methods 0.000 description 2
210000000087 hemolymph Anatomy 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
230000006872 improvement Effects 0.000 description 2
238000001727 in vivo Methods 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
210000004962 mammalian cell Anatomy 0.000 description 2
229930182817 methionine Natural products 0.000 description 2
230000003278 mimic effect Effects 0.000 description 2
230000035772 mutation Effects 0.000 description 2
229940054441 o-phthalaldehyde Drugs 0.000 description 2
230000036961 partial effect Effects 0.000 description 2
ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 2
239000013600 plasmid vector Substances 0.000 description 2
238000012552 review Methods 0.000 description 2
229940016590 sarkosyl Drugs 0.000 description 2
108700004121 sarkosyl Proteins 0.000 description 2
KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 2
125000002264 triphosphate group Chemical class [H]OP(=O)(O[H])OP(=O)(O[H])OP(=O)(O[H])O* 0.000 description 2
238000002604 ultrasonography Methods 0.000 description 2
QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
BFSVOASYOCHEOV-UHFFFAOYSA-N 2-diethylaminoethanol Chemical compound CCN(CC)CCO BFSVOASYOCHEOV-UHFFFAOYSA-N 0.000 description 1
HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
108700010070 Codon Usage Proteins 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
108010066072 DNA modification methylase EcoRI Proteins 0.000 description 1
239000003298 DNA probe Substances 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
241000606675 Ehrlichia ruminantium Species 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
208000034454 F12-related hereditary angioedema with normal C1Inh Diseases 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
239000004471 Glycine Substances 0.000 description 1
108010025076 Holoenzymes Proteins 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
229930010555 Inosine Natural products 0.000 description 1
UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
229910021380 Manganese Chloride Inorganic materials 0.000 description 1
GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
241000713869 Moloney murine leukemia virus Species 0.000 description 1
241001529936 Murinae Species 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
102000057297 Pepsin A Human genes 0.000 description 1
108090000284 Pepsin A Proteins 0.000 description 1
102000002508 Peptide Elongation Factors Human genes 0.000 description 1
108010068204 Peptide Elongation Factors Proteins 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
241000282887 Suidae Species 0.000 description 1
108010008038 Synthetic Vaccines Proteins 0.000 description 1
AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
239000004473 Threonine Substances 0.000 description 1
241000209140 Triticum Species 0.000 description 1
235000021307 Triticum Nutrition 0.000 description 1
108090000631 Trypsin Proteins 0.000 description 1
102000004142 Trypsin Human genes 0.000 description 1
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
241000700605 Viruses Species 0.000 description 1
KITLPLLNIZOYIJ-UUOKFMHZSA-N [[(2r,3s,4r,5r)-5-(2-amino-6-oxo-7,8-dihydro-3h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound C1=2NC(N)=NC(=O)C=2NCN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O KITLPLLNIZOYIJ-UUOKFMHZSA-N 0.000 description 1
CTCBPRXHVPZNHB-VQFZJOCSSA-N [[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate;(2r,3r,4s,5r)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O CTCBPRXHVPZNHB-VQFZJOCSSA-N 0.000 description 1
230000002159 abnormal effect Effects 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
238000005903 acid hydrolysis reaction Methods 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
235000004279 alanine Nutrition 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
235000009582 asparagine Nutrition 0.000 description 1
229960001230 asparagine Drugs 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
238000000211 autoradiogram Methods 0.000 description 1
230000037429 base substitution Effects 0.000 description 1
230000003542 behavioural effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
102000005936 beta-Galactosidase Human genes 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
210000000601 blood cell Anatomy 0.000 description 1
230000005587 bubbling Effects 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
239000004568 cement Substances 0.000 description 1
YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
238000004590 computer program Methods 0.000 description 1
238000001816 cooling Methods 0.000 description 1
NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
239000005547 deoxyribonucleotide Substances 0.000 description 1
125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
230000008021 deposition Effects 0.000 description 1
230000001627 detrimental effect Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000010790 dilution Methods 0.000 description 1
239000012895 dilution Substances 0.000 description 1
239000003937 drug carrier Substances 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
238000001976 enzyme digestion Methods 0.000 description 1
230000008029 eradication Effects 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
238000013401 experimental design Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000002795 fluorescence method Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
230000007614 genetic variation Effects 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
230000005484 gravity Effects 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 1
230000036541 health Effects 0.000 description 1
208000016861 hereditary angioedema type 3 Diseases 0.000 description 1
229940094991 herring sperm dna Drugs 0.000 description 1
239000012145 high-salt buffer Substances 0.000 description 1
238000000703 high-speed centrifugation Methods 0.000 description 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
230000001900 immune effect Effects 0.000 description 1
210000000987 immune system Anatomy 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
238000001114 immunoprecipitation Methods 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
230000008676 import Effects 0.000 description 1
230000006698 induction Effects 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
229960003786 inosine Drugs 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000010354 integration Effects 0.000 description 1
230000002452 interceptive effect Effects 0.000 description 1
239000003456 ion exchange resin Substances 0.000 description 1
229920003303 ion-exchange polymer Polymers 0.000 description 1
AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
229960000310 isoleucine Drugs 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
101150066555 lacZ gene Proteins 0.000 description 1
208000032839 leukemia Diseases 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
238000000464 low-speed centrifugation Methods 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
239000011565 manganese chloride Substances 0.000 description 1
235000002867 manganese chloride Nutrition 0.000 description 1
229940099607 manganese chloride Drugs 0.000 description 1
239000003550 marker Substances 0.000 description 1
238000005259 measurement Methods 0.000 description 1
230000010534 mechanism of action Effects 0.000 description 1
239000002609 medium Substances 0.000 description 1
230000011987 methylation Effects 0.000 description 1
238000007069 methylation reaction Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000000869 mutational effect Effects 0.000 description 1
210000004898 n-terminal fragment Anatomy 0.000 description 1
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
JPXMTWWFLBLUCD-UHFFFAOYSA-N nitro blue tetrazolium(2+) Chemical compound COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 JPXMTWWFLBLUCD-UHFFFAOYSA-N 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
230000008520 organization Effects 0.000 description 1
239000011236 particulate material Substances 0.000 description 1
229940111202 pepsin Drugs 0.000 description 1
238000005191 phase separation Methods 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
238000011176 pooling Methods 0.000 description 1
235000008476 powdered milk Nutrition 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
238000003908 quality control method Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
239000012857 radioactive material Substances 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
210000003079 salivary gland Anatomy 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
238000012216 screening Methods 0.000 description 1
239000006152 selective media Substances 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910052709 silver Inorganic materials 0.000 description 1
239000004332 silver Substances 0.000 description 1
229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
VGTPCRGMBIAPIM-UHFFFAOYSA-M sodium thiocyanate Chemical compound [Na+].[S-]C#N VGTPCRGMBIAPIM-UHFFFAOYSA-M 0.000 description 1
AGDSCTQQXMDDCV-UHFFFAOYSA-M sodium;2-iodoacetate Chemical compound [Na+].[O-]C(=O)CI AGDSCTQQXMDDCV-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000002194 synthesizing effect Effects 0.000 description 1
238000010189 synthetic method Methods 0.000 description 1
238000012360 testing method Methods 0.000 description 1
210000001519 tissue Anatomy 0.000 description 1
UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
239000012588 trypsin Substances 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
239000004474 valine Substances 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Landscapes

Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)

CA 552826 1986-11-27 1987-11-26 Vaccine Expired - Fee Related CA1339466C (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
AUPH9196		1986-11-27
AUPH919686		1986-11-27
AUP12570		1987-06-19
AUP14912		1987-10-16

Publications (1)

Publication Number	Publication Date
CA1339466C true CA1339466C (en)	1997-09-16

Family

ID=3771917

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 552826 Expired - Fee Related CA1339466C (en)	1986-11-27	1987-11-26	Vaccine

Country Status (3)

Country	Link
AU (1)	AU614503B2 (2)
CA (1)	CA1339466C (2)
ZA (1)	ZA878933B (2)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2015054764A1 (pt)	2013-10-16	2015-04-23	Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig	Vacina de peptídeos recombinantes para o controle de carrapatos e sequências de nucleotídeos codificadoras dos peptídeos recombinantes

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995022603A1 (en) *	1994-02-17	1995-08-24	The University Of Melbourne	Vaccine to control ectoparasites

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU598445B2 (en) *	1984-08-08	1990-06-28	Commonwealth Scientific And Industrial Research Organisation	Antigenic extracts derived from boophilus microplus
AU592997B2 (en) *	1985-07-03	1990-02-01	Pitman-Moore Australia Limited	Tick vaccine

1987
- 1987-11-26 CA CA 552826 patent/CA1339466C/en not_active Expired - Fee Related
- 1987-11-27 ZA ZA878933A patent/ZA878933B/xx unknown
- 1987-11-27 AU AU83331/87A patent/AU614503B2/en not_active Expired

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2015054764A1 (pt)	2013-10-16	2015-04-23	Fundação De Amparo À Pesquisa Do Estado De Minas Gerais - Fapemig	Vacina de peptídeos recombinantes para o controle de carrapatos e sequências de nucleotídeos codificadoras dos peptídeos recombinantes

Also Published As

Publication number	Publication date
AU8333187A (en)	1988-06-16
ZA878933B (2)	1988-05-25
AU614503B2 (en)	1991-09-05

Legal Events

Date	Code	Title	Description
2002-09-16	MKLA	Lapsed

Publication	Publication Date	Title
CA1310921C (en)	1992-12-01	Vector for the expression of fusion proteins and protein immunogens
US5780591A (en)	1998-07-14	Protein of Leishmania which is expressed at an increased level in the amastigote form
WO1992010569A1 (en)	1992-06-25	Sperm cell surface protein ph-20. use in a contraceptive vaccine
DE69225357T2 (de)	1998-10-29	Impfstoff gegen Geflügelkokzidose
CA1340858C (en)	1999-12-21	Recombinant and native group b eimeria tenella immunogens useful as coccidiosis vaccines
EP0290565B1 (en)	1996-04-17	Vaccine containing tick antigens
DE68914043T2 (de)	1994-07-07	Coccidiosis-Vakzin.
EP0324648B1 (en)	1994-10-12	Recombinant eimeria tenella vaccines
US6235283B1 (en)	2001-05-22	DNA encoding a cell membrane glycoprotein of a tick gut
US5587311A (en)	1996-12-24	DNA encoding a cell membrane glycoprotein of a tick gut
EP0418310B1 (en)	1996-06-19	Gene for encoding a human malaria vaccine antigen
CA1339466C (en)	1997-09-16	Vaccine
DE68927350T2 (de)	1997-04-24	Gentechnologisch hergestellter coccidiose-impfstoff
US6375955B1 (en)	2002-04-23	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
Kohlstädt et al.	1997	Characterization of a schistosome T cell-stimulating antigen (Sm10) associated with protective immunity in humans
DE69130895T2 (de)	1999-09-30	16-kDa-OBERFLÄCHENPROTEIN VON P. FALCIPARUM
AU676828B2 (en)	1997-03-27	Antigens protective against (echinococcus granulosus) infection and vaccines containing such antigens
DE68909041T2 (de)	1994-01-13	Eimeria tenella-Vakzin.
US5824656A (en)	1998-10-20	Recombinant and native group B eimeria tenella immunogens useful as coccidiosis vaccines
DE69322960T2 (de)	1999-08-12	Empfängnisverhütender impfstoff
DE69530295T2 (de)	2004-05-27	Leishmania hauptprotein, dafür kodierende nukleinsaüre und verwendungen davon
US20040131633A1 (en)	2004-07-08	Parasite antigens

CA1339466C - Vaccine - Google Patents

Info

Links

Landscapes

Applications Claiming Priority (4)

Publications (1)

Family

ID=3771917

Family Applications (1)

Country Status (3)

Cited By (1)

Families Citing this family (1)

Family Cites Families (2)

Cited By (1)

Also Published As

Similar Documents

Legal Events